Abstract The Coronavirus Disease 2019 (COVID-19) pandemic was declared in early 2020
after several unexplained pneumonia cases were first reported in Wuhan, China, and …

Background Progressive respiratory failure is the primary cause of death in the coronavirus
disease 2019 (Covid-19) pandemic. Despite widespread interest in the pathophysiology of …

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) virus has taken an immeasurable toll on humanity, with the …

The endothelium has a fundamental role in the cardiovascular complications of coronavirus
disease 2019 (COVID-19). Infection with severe acute respiratory syndrome coronavirus 2 …

The world is in a hard battle against COVID-19. Endothelial cells are among the most critical
targets of SARS-CoV-2. Dysfunction of endothelium leads to vascular injury following by …

Abstract The coronavirus disease 2019 (COVID-19) infected so far over 250 million people
and caused the death of over 5 million worldwide. Aging, diabetes, and cardiovascular …

The purpose of this article is to follow up on our previous report on microvascular endothelial
dysfunction post-infection with SARS-CoV-2. 1 Since the COVID-19 outbreak caused by …

The role of vascular occlusion in the morbidities, pulmonary and systemic, of COVID-19 has
received increasing focus. Histological studies of lung tissue from COVID-19 patients have …

The pandemic of a new coronavirus started in December 2019 in Wuhan China and is the
cause of a high percentage of the world population infected with symptoms of the Severe …

Increase in thrombotic and microvascular complications is emerging to be a key feature of
patients with critical illness associated with COVID-19 infection. While endotheliopathy is …